Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples